Skip to main content

Churning stocks wobble after reaching record highs

Tuesday, April 6, 2021 | Damian J. Troise, AP Business Writer


In this Nov. 23, 2020 file photo, the New York Stock Exchange is seen in New York. Stocks are opening lower on Wall Street, pulling major indexes slightly below the record highs they reached a day earlier. The S&P 500 fell 0.2% in the early going Tuesday, April 6, 2021. (AP Photo/Seth Wenig, File)

U.S. stocks wobbled between gains and losses on Wall Street in afternoon trading Tuesday as investors shifted to a more cautious mood a day after the market reached its most recent record high.

Technology stocks slipped after seesawing earlier in the day. Financial stocks fell as bond yields eased. That countered broader gains from companies that are depending on continued economic growth to recover.

The S&P 500 index was unchanged as of 1:15 p.m. Eastern. Stocks within the index were nearly evenly split between gainers and losers. The Dow Jones Industrial Average fell 6 points, or 0.2%, to 33,469 and the Nasdaq rose 0.1%.

Much of the churn within the market is occurring as Wall Street assesses the health and speed of the economic recovery. Investors have been weighing concerns about higher inflation as the economy grows, along with expectations that retailers and other service sector stocks will make solid gains as the world moves past the pandemic and returns to some semblance of normalcy.

Gap rose 2.4%, while Wynn Resorts rose 3.4%.

There's been strong support for many of the sectors and companies beaten down by the pandemic as vaccine distribution helps businesses reopen, while government stimulus helps shore up businesses in the interim. Even as that shift occurs, technology and other stocks that benefitted from the shutdowns still look fundamentally strong, said Jeff Buchbinder, equity strategist at LPL Financial.

“We’re seeing this battle play out here in markets every day,” he said. “That's going to drive some churn.”

Bond yields fell. The yield on the 10-year Treasury slipped to 1.66% from 1.72% late Monday. That helped pull banks lower, as they rely on higher yields to charge more lucrative interest on loans. JPMorgan Chase fell 1.1%.

The International Monetary Fund expects global economic growth to accelerate this year as vaccine distribution ramps up and the world rebounds. The 190-country lending agency said it expects the world economy to expand 6% in 2021, up from the 5.5% it had forecast in January. That would be the fastest expansion in IMF records dating back to 1980.

The Labor Department in the U.S. reported that job openings reached the highest level on record in February, a harbinger of healthy hiring and a hopeful sign for those looking for work. That upbeat report follows encouraging reports over the last week on job growth and improvements in the services sector, which is one of the hardest hit areas of the economy from the pandemic.

Swiss bank Credit Suisse said it expects a $4.7 billion loss related to a default of by a U.S. hedge fund. Two top executives are leaving the bank. Credit Suisse also suspended a stock buyback program and cut its dividend. The bank's U.S.-listed shares, which already fell sharply last week after initial news of the default came out, were little changed on Tuesday.

In Europe, France's CAC 40 climbed 0.5%, while Germany's DAX rose 0.8% and Britain's FTSE 100 rose 1.3%. Markets in Asia were mixed.

Featured Article: What is a capital gains distribution?


7 Healthcare Stocks Delivering Innovation in 2021

We all knew that traditional healthcare services were disrupted in 2020. The patient-doctor relationship went virtual. In the early months of the pandemic, many people in need of elective surgeries simply did not have that option available to them. And even local pharmacies took on a new e-commerce role as curbside pickup or home delivery of prescription medication became the norm.

Not surprisingly healthcare stocks were battered last year. Overall, the sector was down 11%, far below the S&P 500 Index that climbed over 15%.

However, the market is always forward-looking with a particular eye towards innovation. The healthcare sector has many companies that are developing innovative approaches in areas such as gene editing. And other companies are in late-stage trials for drugs that can deliver breakthrough results for conditions that continue to plague our world.

That’s the focus of this presentation. We’ve identified 7 healthcare stocks that are delivering innovative ideas that will help deliver better patient outcomes. And in some cases will revolutionize medicine altogether. These are also the stocks that analysts have their eye on.

View the "7 Healthcare Stocks Delivering Innovation in 2021".


Companies Mentioned in This Article

CompanyMarketRank™Current PricePrice ChangeDividend YieldP/E RatioConsensus RatingConsensus Price Target
JPMorgan Chase & Co. (JPM)2.5$164.01flat2.19%21.44Buy$147.99
Compare These Stocks  Add These Stocks to My Watchlist 

MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.